tiprankstipranks
Trending News
More News >
Vor Biopharma (VOR)
NASDAQ:VOR
US Market

Vor Biopharma (VOR) Financial Statements

Compare
767 Followers

Vor Biopharma Financial Overview

Vor Biopharma's market cap is currently $22.07M. The company's EPS TTM is $-0.26; its P/E ratio is ―; Vor Biopharma is scheduled to report earnings on May 8, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -3.49M$ -8.96M$ -4.45M$ -1.39M
Operating Income$ -121.19M$ -126.04M$ -93.42M$ -69.02M$ -43.37M
EBITDA$ -121.19M$ -114.37M$ -90.89M$ -67.58M$ -41.95M
Net Income$ -116.91M$ -117.86M$ -90.77M$ -68.78M$ -43.34M
Balance Sheet
Cash & Short-Term Investments$ 91.93M$ 137.18M$ 230.25M$ 207.47M$ 48.54M
Total Assets$ 142.89M$ 198.13M$ 299.37M$ 242.59M$ 75.91M
Total Debt$ 31.83M$ 35.66M$ 38.91M$ 18.01M$ 18.29M
Net Debt$ -50.12M$ 4.30M$ -18.79M$ -101.79M$ -30.25M
Total Liabilities$ 46.23M$ 47.40M$ 48.76M$ 26.33M$ 27.64M
Stockholders' Equity$ 96.66M$ 150.72M$ 250.61M$ 216.26M$ 48.27M
Cash Flow
Free Cash Flow$ -99.89M$ -101.36M$ -93.61M$ -73.04M$ -40.45M
Operating Cash Flow$ -99.66M$ -100.29M$ -85.14M$ -69.14M$ -36.29M
Investing Cash Flow$ 96.86M$ 71.01M$ -94.09M$ -91.65M$ -4.16M
Financing Cash Flow$ 53.39M$ 2.94M$ 117.14M$ 232.91M$ 82.53M
Currency in USD

Vor Biopharma Earnings and Revenue History

Vor Biopharma Debt to Assets

Vor Biopharma Cash Flow

Vor Biopharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis